Authors: P. Kušnierová 1,2,*; Z. Švagera 1,2; O. Michnová 1; M. Hložánková 3; P. Kosztyu 3; L. Chalupová 3; B. Dvořáková 3; V. Seidlová 3; R. Petr 4; J. Knot 4; R. Koževnikovová 5; J. Cvek 6; D. Stejskal 1,2 Authors‘ workplace: Ústav laboratorní medicíny, Oddělení klinické biochemie, Fakultní nemocnice Ostrava, Ostrava 1; Ústav laboratorní medicíny, Lékařská fakulta, Ostravská univerzita, Ostrava 2; BioVendor - Laboratorní medicína a. s., Brno 3; Kardiologie Praha s. r. o., Praha 4; Medicon a. s., Praha 5; Klinika onkologická, Lékařská fakulta, Ostravská univerzita a Fakultní nemocnice Ostrava, Ostrava 6 Published in: Klin. Biochem. Metab., 31, 2023, No. 1, p. 16-20 doi: https://doi.org/10.61568/kbm.2023.004
MicroRNAs are very stable short (18-24) noncoding RNAs. The function of miRNA molecules includes everything from the regulation of key signalling pathways at the molecular level to the rapid cellular response to pathological conditions. miRNAs are stable in body fluids and represent a very promising diagnostic targets for the early identification of a wide range of diseases. This summary article provides an overview of candidate diagnostic miRNAs suitable for use in the diagnosis of oncological cardiotoxicity.
cardiotoxicity – microRNA – oncology
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
